Shorla Oncology | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Data insights Regulatory

3 December 2024

FDA red and green lights: November 2024

Autolous, Syndax, Jazz and Shorla get US approvals in a quiet month.

Data insights

31 October 2024

The month ahead: November’s upcoming events

Conferences ramp up, and ASH abstracts near.

Subscribe to Shorla Oncology